- Medical school graduates per 100,000 residents, by state
- 4 states tackling hospital violence prevention in 2026
- ChristianaCare hospital president exits, steps into CEO role
- New study highlights public divide over community water fluoridation: 5 notes
- What to know about MultiPlan’s litigation saga
- Missouri system taps interim market leader following 4-hospital deal
- CMS puts Medicaid demonstration waivers on a tighter leash: 5 notes
- VHC Health impacted by vendor phishing attack
- Judy Faulkner wins Cambridge Health Alliance’s Art of Healing Award
- Nvidia, Aetna, Cigna, Eli Lilly: Abridge’s new partnerships make good on its name
- Arizona MOBs acquired for $48M
- Iowa Dental Board suspends dentist’s license
- Healthcare faces ‘watershed moment’ with costs jumping 9% in 2027: 7 things to know
- Where are physicians moving?
- Orthopedic surgeon pay has increased 22% since 2021
- Novant Health expands GI network in South Carolina
- The region quietly becoming the most competitive anesthesiologist markets
- The hidden income gap between employed and independent physicians in 2026
- The $111M physician acquisition that ended South Carolina’s independent medicine era
- 5 DSO milestones in 3 weeks
- Why this behavioral health provider just bought a pharmacy
- Dentsply Sirona appoints executive VP, CFO
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- North Carolina awards $10M to expand rural behavioral healthcare access
- Where 5 behavioral health leaders are betting big on technology
- The 10 states where CRNA pay exploded
- Only 3% of Americans associate oral health with overall well-being: Study
- New Florida retail property with an Aspen Dental sells for $11M
- The physician specialty facing the biggest pay cut in 2026
- Healthcare costs poised to jump 9% in 2027 as health plans blame AI adoption, drug prices
- Hackensack Meridian opens behavioral health expansion amid 30% rise in youth admissions
- Feds find errors in all prior authorization denials at Philadelphia behavioral health insurer
- 30 behavioral health executive moves to know
- 600,000 cases could finally settle the outpatient spine debate
- Provider groups file lawsuit against HHS over anti-trans Ryan White funding rules
- Genentech executes another round of layoffs, with 3 VPs axed
- Humana to sell off minority stake in end-of-life care provider Gentiva
- Vitamin C May Be Key To A Healthier Brain As You Age
- New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Novo reports data breach, tells clinical trial patients to 'remain vigilant'
- ‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff
- OIG: Frequent MA prior authorization denials for long-term care hospitals, inpatient rehab
- From Medicaid work requirement exemptions to AI safeguards in coverage: New AMA policies from annual meeting
- Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure
- J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win
- Virtual care tech companies launch 'out-of-the-box' RPM tool for pharmacies
- Can Fasting Treat Gum Disease? Study Finds Reduced Inflammation
- Living With Cats Not Linked To Worse Asthma in Children
- Few Stroke, Brain Injury Survivors Get Top-Quality Hospital Rehab
- Popular Joint Pain Supplement, Glucosamine, Might Increase Alzheimer's Risk, Study Says
- Anguished Parents. Doctors In Tears. Utah's Long Measles Outbreak Takes A Toll.
- Madrigal takes giant inflatable liver on US tour in disease awareness push
- Listen to the Latest ‘KFF Health News Minute’
- Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards
- Olixir NY teams with Crohn's & Colitis Foundation for ‘Spill Your Guts’ campaign
- Takeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdown
- Hospital associations push CMS for higher 2027 pay bump, softer ramp-up for mandatory model
- AHIP 2026: Why Ascendiun CEO Paul Markovich is bullish on building out a digital health record for patients
- The model rebuilding healthcare’s ‘front door’ — and dentistry’s role in it
- Michigan bill would create state dental insurance exchange: 3 notes
- 6 dental companies ranked among ‘America’s Greatest Workplaces in Health Care’: Newsweek
- Marshfield Clinic awards 60 behavioral health grants to schools, community groups
- 3 dental companies ranked among ‘best companies for the future’: WSJ
- FDA’s Greenlight of Old Chemical Offers Chance To Restore Faith in Sunscreen
- Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows
- Drug overdose deaths fall in 42 states: 5 things to know
- Psychiatry, psychology groups urge Aetna to pause reimbursement cuts for behavioral health clinicians
- New Mexico hospital opens $36M children’s psychiatric center
- Sugary Beverages May Raise Your Risk of Liver Cancer
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Ardent Health's surprise CEO change reflected need for margin focus amid headwinds, CFO says
- FDA Approves First New Sunscreen Ingredient, Bemotrizinol, in Two Decades
- Trustees expect Medicare Trust Fund's reserves to run out in 2033
- WellSpan reports 66% workplace violence reduction with Canopy's safety tech
- Vega Health licenses AI models from Parkland Center for Clinical Innovation to predict patient risks
- Eli Lilly yells ‘action’ on authentic patient portrayals at Tribeca Festival
- Teen Recovering From Concussion? A 'Sweet Spot' For Screen Time Could Speed Up Their Recovery
- Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters
- AMA issues policy urging exemptions in upcoming Medicaid work requirements
- Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
- Teva to lay off 250 at API unit as search for new owner drags on: report
- Women Hit Harder By Sleep Apnea Than Men, Study Finds
- Retro Video Game Aids Stroke Recovery, Improves Arm Function
- UnitedHealthcare exec talks AI, affordability and member engagement
- Experimental, Once-Daily GLP-1 Pill, Elecoglipron, May Offer New Option for Weight Loss, Diabetes
- Anguished Parents. Doctors in Tears. Utah’s Long Measles Outbreak Takes a Toll.
- Looming Medicaid Cuts Supercharge California’s Latest Labor-Industry Fight
- Genentech and Novartis dish up food allergy microdrama series
- ‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO
- AHIP 2026: CAQH rebrands as DataSpring as it charts course for the future
- House Appropriations Committee takes aim at CMS' WISeR pilot
- PCMA unveils new policy platform aimed at drug affordability
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- CalOptima Health approves $430M rate increase to keep safety-net providers afloat
- PSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models
- How Much Alcohol Is Actually Safe? A New Study Challenges Old Advice
- AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings
- Alignment Health CEO 'very confident' in Q2 guidance as insurer eyes market expansion
- Hundreds of hospitals warned over price transparency failings, AP reports
- Air Pollution Might Contribute To Clogged Arteries, Heart Disease Risk
- New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
- WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
- Merck, Gilead score in effort to develop the first weekly HIV pill
- As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AZ and Daiichi rivals
- Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
- At A Tennessee Hospital, Nurse Stole Fentanyl And AI Missed It, State Records Say
- Infections A ‘Major Health Hazard’ For People With Diabetes, Large Study Warns
- MAHA's Treatments For Autism: Camel's Milk, Stem Cell Injections — And Spelling Therapy
- Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide
- Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide
- AI medical advice changes care decisions of most users: survey
- AstraZeneca reprimanded over LinkedIn likes once again
- FDA Expands Sunscreen Options for the First Time in 20 Years
- Children's Well-Being Plummets Across 29 States, Report Finds
- ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes
- With ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity race
- Just 5 Minutes Of Prayer Helps Reduce Pain and Anxiety, Study Finds
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Irregular Sleep Risks Preschool Kids' Brain Power
- Why Alcohol Makes You Crave Salty Snacks — And How Protein-Rich Foods Can Help Prevent Weight Gain
- ADHD ‘Masking’ May Help People Blend In But Harms Mental Health
- Getting The RSV Shot, Abrysvo, While Pregnant Could Protect Your Baby After Birth
- Upcoming Billing Change Could Make Pregnancy Pricier
- By September, Nearly a Third of Americans Will Live in States With Legal Aid in Dying
- MAHA’s Treatments for Autism: Camel’s Milk, Stem Cell Injections — And Spelling Therapy
- Gounder Fills In Details Behind Ebola, GLP-1, and Trump Headlines
- Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
- Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
- Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
- Too Much Sitting In Pregnancy Doubles Risk Of Complications
- Spinal Cord Stimulation May Restore Arm Strength After Stroke
- RFK Jr. Seeks To Peek At Americans' Medical Records For Clues On Autism And Vaccines
- Two-Pill Combo, Inqovi and Venclexta, Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Poll Finds Broad Support For Stricter Regulations On Ultra-Processed Foods
- Remarks at the Investor Advisory Committee Meeting
- Nearly 1 in 5 Young People Turn to AI Chatbots for Mental Health Advice
- Older LGBTQ+ Adults Fear Less Support As They Age, Poll Shows
- Night Owls Are More Prone To Anxiety, Loneliness
- Home-Delivered Medical Meals Reduce ER Visits, Save Money
- Base Case: Remarks at the IC3 Blockchain Camp
Michigan healthcare freedom community forum
Chris Pope of The Manhattan Institute believes that preventing states from creating new, extraneous programs and funding them with Medicaid dollars is the best way to cut Medicaid spending. A good idea, but unlikely to actually cut Medicaid spending. More likely to reduce the explosive growth of Medicaid spending which has occurred in this century. Federal Medicaid expenditures have increased from $ 118 billion in FY2000 to $ 557 billion in FY2024, a 472% increase:
https://www.city-journal.org/article/house-republicans-medicaid-spending-proposals
A Better Way to Cut Medicaid Spending
The House GOP’s current plans won’t significantly reduce the program. Republicans should instead seek to slow states’ expansions of it.
By Chris Pope - May 20, 2025Last week, House Republicans unveiled proposals to reform Medicaid, the fast-growing system of federal funding for states to deliver health care to low-income Americans. Their proposal creates the appearance of generating substantial savings by nudging states to restrict enrollment. But the approach is unlikely to slow the overall growth of Medicaid spending, because it does little to reduce states’ ability and incentive to claim ever more federal funding.
In reality, Republicans, who promised not to threaten care for those enrolled, have been unable to identify substantial savings by cutting funds that states rely on to deliver health care to Medicaid enrollees. They would do better to focus on the politically easier and fiscally more significant task of preventing states from further expanding the program’s commitments.
Liberals responded to the House’s modest proposals with predictable outrage. Matthew Yglesias has called it a “War on the poor,” arguing that “Medicaid cuts contained in the bill will cause 8.6 million people to lose their health insurance.” Massachusetts representative Lori Trahan has deemed it “federal overreach, plain and simple, with devastating consequences for the people we represent.”
Critics’ outrage is surely overdone. From 2003 to 2023, Medicaid’s annual cost to federal taxpayers surged from $161 billion to $616 billion. House Republicans’ proposals would merely slow the program’s further spending growth over the coming decade from 4.6 percent per year to 3.7 percent. Even that reduction in growth is likely to overestimate the savings that would occur.
To offset the cost of extending the 2017 tax cuts, the House GOP has attempted to maximize the Congressional Budget Office’s estimate of savings resulting from its proposed reforms to Medicaid. But CBO estimates don’t account for likely hurdles to implementation, such as states finding ways to evade intended cost controls.
When such hurdles are considered, the savings and coverage loss are both much less than they’re cracked up to be. This is by design—and it reflects the GOP’s tiny majorities in both houses of Congress, combined with political pressure from governors and health-care providers who stand to lose revenues.
Opponents of the bill point to major cuts in coverage, which the CBO suggests would generate reductions in spending. Loren Adler and Matthew Fiedler of the Brookings Institution, for example, argue that “House Republicans are cutting health coverage programs in two basic ways: (1) narrowing eligibility and making it harder to enroll and stay enrolled; and (2) shifting Medicaid costs from the federal government to the states.” But neither of these effects are likely to be that large.
Take the bill’s work requirements. Adler and Fielder concede that work requirements would not greatly narrow eligibility because the “overwhelming majority of affected enrollees are already working or otherwise complying.” But they suggest that the administrative burden of demonstrating compliance may lead many who are eligible to lose benefits.
That seems unlikely. The bill allows part-time “community engagement” activities to satisfy work requirements, and states have proven adept at using token employment arrangements to nullify similar mandates in the past. The bill would not even allow states to implement work requirements for several years.
States currently receive up to $9 in federal funds for every $1 they spend on Medicaid benefits for able-bodied adults—a return on investment that even most conservative states have found hard to resist. An important objective of work requirements appears to be giving the remaining holdouts political cover to claim their own portion of the federal bounty by expanding Medicaid. This would greatly increase, rather than reduce, federal spending and Medicaid enrollment—even if CBO does not account for such considerations.
Republicans argue that it’s absurd for the federal government to provide $9 in funding for every $1 states spend on Medicaid benefits for able-bodied adults, while only providing an average of $1.30 for every $1 spent on benefits for children, the disabled, and pregnant women. President Obama proposed replacing this arrangement with an intermediary rate for all beneficiaries, but Republicans plan simply to reduce the higher rate.
Democrats argue that the proposed reduction of funding for states would lead to major cuts in coverage. But the GOP bill would only trim the $9-to-$1 match to $8-to-$1 for blue states whose Medicaid providers also deliver care to illegal immigrants—leaving an enormously lucrative arrangement largely in place. The reduction is more an attempt to influence states’ policies on immigration than an effort to lessen substantially the burden on federal taxpayers.
The House GOP bill may nonetheless generate some modest genuine savings. It tightens enforcement of means tests and attempts to restrict states’ ability to inflate federal matching funds artificially by imposing state taxes on insurers, hospitals, and other medical providers. But similar restrictions on “provider taxes” have been enacted in the past and tend to proceed like a game of Whac-a-Mole: whenever Congress restricts one scheme to inflate Medicaid costs artificially, states construct another.
The only real way to stop states from driving up Medicaid costs is to limit the total amount of federal Medicaid funding each state may claim. This year’s House GOP proposal, unlike the 2017 version, doesn’t even try to do so. The GOP has previously stumbled in attempting to set precise dollar limits on Medicaid funding for states. (Set them too high, and they will do little to constrain the growth of expenditures; too low, and they will unduly disrupt existing care.)
A better approach would be to prohibit high-spending states from unilaterally expanding their Medicaid programs. States that claim more than $20,000 in federal Medicaid funds per poor resident should no longer be permitted to claim additional matching funds for further expansions of benefit packages or eligibility, or extraordinary increases in payments for services undertaken without express authorization by Congress.
The House GOP’s Medicaid reform proposals have failed to generate substantial genuine savings or improvements to the program. Their Republican Senate counterparts have an opportunity to do better.
Christopher Pope is a senior fellow at the Manhattan Institute. Previously, he was director of policy research at West Health, a nonprofit medical research organization; health-policy fellow at the U.S. House Committee on Energy and Commerce; and research manager at the American Enterprise Institute. Pope’s research focuses on healthcare payment policy, and he has recently published reports on hospital-market regulation, entitlement design, and insurance-market reform. His work has appeared in, among others, the Wall Street Journal, Health Affairs, US News and World Report, and Politico.
Pope holds a B.Sc. in government and economics from the London School of Economics and an M.A. and Ph.D. in political science from Washington University in St. Louis.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















